Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Endofar is an Italian pharmaceutical and nutraceutical company headquartered in Rome, specializing in the development of therapeutic solutions for gastroenterology, gynecology, orthopedics, and urology. The company focuses on high-quality food supplements and medical devices that address specific clinical needs, such as inflammatory processes and metabolic support. Endofar's product portfolio is characterized by the use of the "Endo-" prefix, featuring established brands like Endofit for gastrointestinal health and Endoflog for musculoskeletal inflammation. The company emphasizes scientific research and collaboration with medical specialists to provide evidence-based health solutions that complement traditional pharmacological treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ENDOFAR.